Jarosław W.
- Country
- Poland
- Department
- Gastroenterology
Research Overview
Data & Insights
Has run more than one trial at 0 of 110 partner sites.
Specializations
Bladder Cancer and Non-Muscle Invasive Bladder Cancer
Jarosław Witkowski is involved in clinical research focused on urinary bladder neoplasms, with particular attention to high-risk non-muscle invasive bladder cancer, BCG-unresponsive disease, and carcinoma in situ. His trial activity also includes advanced and metastatic transitional cell carcinoma within the broader field of uro-oncology.
- High-risk NMIBC
- BCG-unresponsive bladder cancer
- Carcinoma in situ
- Advanced urinary tract cancer
The research profile reflects a strong therapeutic interest in intravesical and systemic approaches for bladder cancer control, recurrence prevention, and disease progression management.
Ulcerative Colitis and Inflammatory Bowel Disease
His gastroenterology-based research includes ulcerative colitis, ranging from mild to moderately active disease to more severe inflammatory presentations. The clinical focus extends to remission induction and symptom control in chronic inflammatory bowel disease.
- Ulcerative colitis
- Clinical remission
- Endoscopic disease activity
- Inflammatory bowel disease
This area places emphasis on therapies aimed at reducing intestinal inflammation and improving mucosal healing in patients with active colonic disease.
Chronic Kidney Disease and Cardiorenal Risk
Jarosław Witkowski is also engaged in research on chronic kidney disease with albuminuria and hypertension, including therapeutic strategies intended to slow renal decline and reduce associated cardiovascular risk. His interests include conditions where kidney dysfunction overlaps with heart failure prevention.
- Chronic kidney disease
- Albuminuria
- Hypertension
- Heart failure prevention
The therapeutic scope includes cardiorenal protection, renal outcome preservation, and management of patients at elevated cardiovascular risk.
Autoimmune and Inflammatory Disorders
His clinical trial portfolio includes dermatomyositis and other immune-mediated conditions, reflecting involvement in therapies for systemic inflammation and autoimmune disease control. This interest sits alongside broader treatment areas where immune modulation is central to clinical benefit.
- Dermatomyositis
- Autoimmune disease
- Systemic inflammation
- Immune-mediated disorders
The research landscape includes therapeutic evaluation of agents intended to address inflammatory activity and related symptom burden across multisystem disease.
Metabolic and Functional Symptom Research
Additional clinical involvement covers overweight and obesity with type 2 diabetes, vasomotor symptoms linked to endocrine therapy, and urinary incontinence. These areas show interest in symptom relief and metabolic risk reduction across common chronic conditions.
- Type 2 diabetes
- Obesity
- Vasomotor symptoms
- Stress urinary incontinence
His trial activity in this domain spans metabolic disease management and therapies targeting quality-of-life symptoms with functional impact.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.